Q&A: Bacteria research could be a gut-punch to inflammatory bowel disease

The group of lifelong intestinal conditions known as inflammatory bowel disease (IBD), which includes Crohn's disease and ...

J&J submits application to FDA for expanded use of Stelara

Johnson & Johnson (JNJ) has submitted a new application to the U.S. FDA to expand the use of Stelara (ustekinumab) for treating children aged two and older with moderate to severe ulcerative colitis.
Fierce Pharma

AbbVie boosts revenue forecast by $400M thanks to booming sales of Skyrizi, Rinvoq

For the third straight quarter, AbbVie has jacked up its revenue forecast for 2025. The Illinois drugmaker has raised its guidance by $400 million, now expecting sales to reach $60.9 billion. | ...
Gastroenterology Advisor

FDA Approves Omvoh Single-Injection Maintenance Regimen for Ulcerative Colitis

The new approval allows patients to transition to a single 200mg subcutaneous injection once every 4 weeks, following completion of the induction phase.
Medscape

Gastrointestinal Bacterial Infections May Trigger IBD Flares

In patients with inflammatory bowel disease, severe gastrointestinal infections may trigger disease flares, requiring ...
The Suburban

Dr. Talat Bessissow to be honoured by the McGill IBD Research Group

The McGill IBD Research Group, in partnership with the Montreal General Hospital Foundation, will hold its annual fundraising ...